Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Universitair Ziekenhuis Gent
Sponsor

Universitair Ziekenhuis Gent

Belgium Corneel Heymanslaan 10, 9000 Gent, Belgium

About the sponsor

Universitair Ziekenhuis Gent supports research in oncology with a strong focus on imaging-based assessment and treatment selection across several malignancies, including metastatic non-small-cell lung cancer, hepatocellular carcinoma, thyroid carcinoma, head and neck squamous cell carcinoma, glioblastoma, breast cancer, and oligorecurrent prostate cancer.

  • Positron emission tomography and tumor staging
  • Prostate-specific membrane antigen-directed imaging
  • Radiotherapy and systemic treatment strategies
  • Immunotherapy in advanced solid tumors

Its research activity also includes imaging-guided evaluation of metastatic and recurrent disease, with interest in peritoneal metastases and response assessment in advanced cancer settings.

About Specializations

Universitair Ziekenhuis Gent runs clinical trials in conditions such as Infertility, Haematological malignancy, Abdominal infection, Pneumonia bacterial, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

19 clinical trials

Haematological malignancy

Recruiting

Study of fludarabine phosphate in patients with blood cancer undergoing lymphodepletion before CAR-T cell therapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Universitair Ziekenhuis Gent

Abdominal infection+3

Recruiting

Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cefotaxime
  • Sponsor:Universitair Ziekenhuis Gent

Hepatocellular carcinoma

Recruiting

Study on F-18 PSMA-11 PET Imaging for Liver Cancer in Patients to Evaluate Survival

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide ALF-18
  • Sponsor:Universitair Ziekenhuis Gent

Psoriasis

Recruiting

Study on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Universitair Ziekenhuis Gent

Critical illness

Recruiting

Study of amoxicillin-clavulanic acid, piperacillin-tazobactam and meropenem dosing in critically ill children with systemic infections

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Ziekenhuis Gent

Allogenic stem cell transplantation

Recruiting

Study on Fludarabine, Melphalan, and ATG for Patients with Blood Cancer Undergoing Reduced Intensity Stem Cell Transplantation

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Melphalan
  • Sponsor:Universitair Ziekenhuis Gent

Infertility

Recruiting

Study Comparing Corifollitropin Alfa and Modified Natural Cycles for Women with Subfertility and Low Ovarian Response

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Corifollitropin Alfa
  • Sponsor:Universitair Ziekenhuis Gent

Coronary artery disease

Recruiting

Study on Colchicine for Patients with Coronary Artery Disease After Percutaneous Coronary Intervention

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Az St-Jan Brugge-Oostende A.V.

Infertility

Recruiting

Study Comparing Corifollitropin Alfa and Progestin Primed Ovarian Stimulation for Women with Subfertility Undergoing Elective Fertility Preservation or Genetic Testing

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Corifollitropin Alfa
  • Sponsor:Universitair Ziekenhuis Gent

Axial spondyloarthritis

Recruiting

Study on Axial Spondyloarthritis Treatment Using Technetium-Labeled Certolizumab Pegol for Patients with Axial Spondyloarthritis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Technetium (99MTC) certolizumab pegol
  • Sponsor:Universitair Ziekenhuis Gent

Endotracheal intubation

Recruiting

Study on Remifentanil and Sodium Chloride for Safe Intubation in Stable Newborns

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Remifentanil
  • Sponsor:Universitair Ziekenhuis Gent

Thyroid cancer+1

Recruiting

Study on [18F]PSMA-11 PET Imaging for Patients with Advanced Thyroid and Head and Neck Cancer

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide ALF-18
  • Sponsor:Universitair Ziekenhuis Gent

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.